Collaborations

Neurotech has established several research collaborations with world-renowned investigators in leading research institutes and universities in the USA and Europe and include the National Eye Institute, USA, the University of Pennsylvania and the University of Miami/Bascom Palmer Eye Institute. These collaborations allow Neurotech to access expertise from leading distinguished scientists and clinicians who are recognized opinion leaders in either discovery, research and in vivo models, surgical techniques or clinical development. Some of these relationships are described below:

The National Eye Institute, Bethesda, MD, committed substantial resources by assuming investigational responsibility for the initial clinical evaluation of ECT-mediated delivery of CNTF in patients with retinitis pigmentosa (Phase I).

Neurotech has also had a long relationship with the Foundation Fighting Blindness, Baltimore, MD., one of the world’s leading charitable organizations dedicated to finding cures for diseases of the eye. The Foundation recognized the potential of ECT as an intraocular therapeutic drug delivery technology for retinal diseases and provided critical funding for an initial preclinical proof of principle study.

Neurotech values these relationships, which provide a continuous, high quality source of information on new developments in ophthalmology and provide valuable feedback regarding product design enhancements. The company will continue to explore the potential to establish new relationships to strengthen its technology to meet unmet patient needs in the field of retinal medicine.